Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...
Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback